Butterfly Network (BFLY) | Financial Analysis & Statements
Butterfly Network Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
31.5M
Gross Profit
21.2M
67.34%
Operating Income
-16.7M
-53.03%
Net Income
-15.3M
-48.52%
Balance Sheet Metrics
Total Assets
296.5M
Total Liabilities
100.6M
Shareholders Equity
196.0M
Debt to Equity
0.51
Cash Flow Metrics
Operating Cash Flow
5.6M
Free Cash Flow
7.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Butterfly Network Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 97.6M | 82.1M | 65.9M | 73.4M | 62.6M |
| Cost of Goods Sold | 51.9M | 33.2M | 49.0M | 33.9M | 45.5M |
| Gross Profit | 45.7M | 48.8M | 16.9M | 39.5M | 17.1M |
| Gross Margin % | 46.9% | 59.5% | 25.6% | 53.8% | 27.3% |
| Operating Expenses | |||||
| Research & Development | 36.3M | 37.8M | 55.6M | 88.0M | 74.5M |
| Selling, General & Administrative | 95.9M | 85.4M | 88.7M | 137.1M | 135.3M |
| Other Operating Expenses | - | - | 18.2M | 7.3M | - |
| Total Operating Expenses | 132.1M | 123.2M | 162.5M | 232.5M | 209.8M |
| Operating Income | -86.4M | -74.4M | -145.6M | -193.0M | -192.7M |
| Operating Margin % | -88.5% | -90.7% | -221.0% | -263.0% | -308.0% |
| Non-Operating Items | |||||
| Interest Income | 5.9M | 5.0M | 7.4M | 3.4M | 2.6M |
| Interest Expense | 1.5M | 1.3M | 0 | 2.0K | 651.0K |
| Other Non-Operating Income | 5.0M | -1.9M | 4.5M | 21.0M | 158.5M |
| Pre-tax Income | -77.0M | -72.5M | -133.6M | -168.7M | -32.3M |
| Income Tax | 110.0K | -32.0K | 82.0K | 42.0K | 121.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -77.1M | -72.5M | -133.7M | -168.7M | -32.4M |
| Net Margin % | -79.0% | -88.3% | -202.9% | -229.9% | -51.8% |
| Key Metrics | |||||
| EBITDA | -69.7M | -59.1M | -127.6M | -183.6M | -190.6M |
| EPS (Basic) | $-0.31 | $-0.34 | $-0.65 | $-0.84 | $-0.19 |
| EPS (Diluted) | $-0.31 | $-0.34 | $-0.65 | $-0.84 | $-0.19 |
| Basic Shares Outstanding | 247124365 | 211682760 | 205385544 | 199848386 | 173810053 |
| Diluted Shares Outstanding | 247124365 | 211682760 | 205385544 | 199848386 | 173810053 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Butterfly Network Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 150.5M | 88.8M | 134.4M | 162.6M | 422.8M |
| Short-term Investments | - | - | 0 | 75.2M | 0 |
| Accounts Receivable | 26.7M | 20.8M | 13.4M | 14.7M | 11.9M |
| Inventory | 61.4M | 70.8M | 73.0M | 60.0M | 36.2M |
| Other Current Assets | 8.4M | 6.7M | 7.6M | 9.5M | 13.4M |
| Total Current Assets | 249.1M | 192.6M | 231.3M | 357.1M | 511.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 12.7M | 14.3M | 15.7M | 21.7M | 24.1M |
| Goodwill | 30.9M | 29.6M | 10.3M | 0 | - |
| Intangible Assets | 30.9M | 29.6M | 10.3M | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.6M | 4.8M | 5.4M | 5.7M | 6.6M |
| Total Non-Current Assets | 47.4M | 63.5M | 73.0M | 60.4M | 60.1M |
| Total Assets | 296.5M | 256.1M | 304.3M | 417.6M | 572.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.4M | 4.2M | 5.1M | 7.2M | 5.8M |
| Short-term Debt | 2.7M | 2.4M | 2.2M | 1.9M | 1.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 9.7M | 9.2M | 7.8M | 6.8M | 6.0M |
| Total Current Liabilities | 65.1M | 48.2M | 44.3M | 51.3M | 49.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 17.7M | 20.4M | 22.8M | 30.0M | 27.7M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 8.3M | 8.6M | 8.9M | 588.0K | 850.0K |
| Total Non-Current Liabilities | 35.4M | 39.0M | 40.0M | 40.9M | 74.4M |
| Total Liabilities | 100.6M | 87.2M | 84.2M | 92.2M | 124.3M |
| Equity | |||||
| Common Stock | 26.0K | 22.0K | 21.0K | 20.0K | 20.0K |
| Retained Earnings | -879.2M | -802.1M | -729.6M | -595.9M | -427.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 196.0M | 168.8M | 220.1M | 325.4M | 447.7M |
| Key Metrics | |||||
| Total Debt | 20.4M | 22.8M | 25.0M | 31.9M | 29.1M |
| Working Capital | 184.0M | 144.4M | 187.0M | 305.8M | 462.1M |
Balance Sheet Composition
Butterfly Network Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -77.1M | -72.5M | -133.7M | -168.7M | -32.4M |
| Depreciation & Amortization | 8.1M | 10.3M | 10.6M | 5.9M | 2.1M |
| Stock-Based Compensation | 23.4M | 21.0M | 27.5M | 42.5M | 47.8M |
| Working Capital Changes | 7.9M | -7.4M | -34.6M | -21.8M | -18.7M |
| Operating Cash Flow | -35.4M | -46.2M | -129.8M | -141.5M | 1.0M |
| Investing Activities | |||||
| Capital Expenditures | -3.3M | -2.7M | -5.8M | -18.2M | -7.9M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | 0 | 0 | -297.0K | -75.5M | -1.0B |
| Investment Sales | 0 | 0 | 76.5M | 0 | 1.0B |
| Investing Cash Flow | -3.3M | -2.7M | 70.4M | -93.8M | -9.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | 0 | 0 |
| Debt Repayment | - | - | 0 | 0 | -4.4M |
| Financing Cash Flow | 75.5M | -2.1M | 0 | -101.0K | 1.1B |
| Free Cash Flow | -16.0M | -44.4M | -104.6M | -187.4M | -197.1M |
| Net Change in Cash | 36.8M | -50.9M | -59.4M | -235.4M | 1.1B |
Cash Flow Trend
Butterfly Network Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-16.65
Forward P/E
-55.30
Price to Book
7.16
Price to Sales
14.43
PEG Ratio
0.67
Profitability Ratios
Profit Margin
-78.95%
Operating Margin
-36.13%
Return on Equity
-42.25%
Return on Assets
-13.17%
Financial Health
Current Ratio
3.82
Debt to Equity
10.41
Beta
2.22
Per Share Data
EPS (TTM)
$-0.31
Book Value per Share
$0.77
Revenue per Share
$0.40
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BFLY | 1.3B | -16.65 | 7.16 | -42.25% | -78.95% | 10.41 |
| Abbott Laboratories | 160.7B | 25.97 | 3.09 | 12.36% | 13.90% | 26.79 |
| Stryker | 126.3B | 39.21 | 5.62 | 15.08% | 12.92% | 72.97 |
| Axogen | 1.9B | -110.18 | 13.15 | -13.49% | -6.97% | 55.50 |
| Establishment Labs | 1.9B | -37.89 | 79.68 | -133.25% | -24.19% | 1,123.15 |
| Artivion | 1.8B | 179.71 | 4.03 | 2.70% | 2.21% | 57.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.






